lodoxamide ethyl has been researched along with 1,7-phenanthroline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caltabiano, G; Charlton, SJ; Fawcett, L; Hudson, BD; Jenkins, L; Kent, TC; MacKenzie, AE; Markwick, R; McCallum, JE; Milligan, G; Nicklin, SA | 1 |
1 other study(ies) available for lodoxamide ethyl and 1,7-phenanthroline
Article | Year |
---|---|
The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35.
Topics: Animals; Anti-Allergic Agents; Cell Line; Computer Simulation; Cricetinae; Cricetulus; Humans; Mast Cells; Molecular Docking Simulation; Mutation; Oxamic Acid; Phenanthrolines; Polymorphism, Single Nucleotide; Rats; Receptors, G-Protein-Coupled | 2014 |